Ryan Weispfenning: Good morning, I m Ryan Weispfenning, Vice President and Head of Medtronic Investor Relations. Welcome to Minnesota, land of 10,000 lakes.
This randomized clinical trial compares the efficacy of intensive glucose management, which included use of an automated insulin delivery system, vs standard ca